SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AC0. A total of 20 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $45,000 | +50.0% | 12,000 | 0.0% | 0.00% | – |
| Q4 2014 | $30,000 | -25.0% | 12,000 | 0.0% | 0.00% | – |
| Q3 2014 | $40,000 | -99.7% | 12,000 | -99.8% | 0.00% | -100.0% |
| Q1 2014 | $13,167,000 | -38.4% | 5,873,000 | -46.0% | 0.00% | -42.9% |
| Q4 2013 | $21,381,000 | +24196.6% | 10,867,000 | +16618.5% | 0.01% | – |
| Q2 2012 | $88,000 | +125.6% | 65,000 | +124.1% | 0.00% | – |
| Q1 2012 | $39,000 | – | 29,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 219,440,000 | $431,748,000 | 6.08% |
| SYMPHONY ASSET MANAGEMENT LLC | 12,727,000 | $25,040,000 | 1.83% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,000,000 | $41,318,000 | 0.49% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 600,000 | $1,184,000 | 0.48% |
| SHENKMAN CAPITAL MANAGEMENT INC | 200,000 | $395,000 | 0.04% |
| Citadel Advisors | 11,000,000 | $21,696,000 | 0.03% |
| PEAK6 Group LLC | 15,000 | $2,951,000 | 0.02% |
| FRANKLIN RESOURCES INC | 17,290,000 | $34,071,000 | 0.02% |
| LORD, ABBETT & CO. LLC | 3,243,000 | $6,397,000 | 0.01% |
| EULAV Asset Management | 123,000 | $242,000 | 0.01% |